Current Status and Prospects of Immunotherapy for Gynecologic Melanoma

Gynecologic melanomas are rare and have a poor prognosis. Although immunotherapy (immune checkpoint inhibitors) and targeted therapy has greatly improved the systemic treatment of cutaneous melanoma (CM) in recent years, its efficacy in gynecologic melanomas remains uncertain because of the rarity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Anko, Mayuka, Kobayashi, Yusuke, Banno, Kouji, Aoki, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151394/
https://www.ncbi.nlm.nih.gov/pubmed/34065883
http://dx.doi.org/10.3390/jpm11050403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151394/
https://www.ncbi.nlm.nih.gov/pubmed/34065883
http://dx.doi.org/10.3390/jpm11050403

Ejemplares similares